Improvement of allergic dermatitis via regulation of the Th1/Th2 immune system balance by macrophages activated with lipopolysaccharide derived from Pantoea agglomerans (IP-PA1)

Anticancer Research

Volumn 29, Issue 11, 2009, Pages 4867-4870

  Yoshida, Aya ^a,b,e   Kohchi, Chie ^a,b,c,e   Inagawa, Hiroyuki ^a,c,d,e   Nishizawa, Takashi ^a,e   Soma, Gen Ichiro ^a,b,c  

^a TOKUSHIMA BUNRI UNIVERSITY   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

^c TOKYO UNIVERSITY OF SCIENCE   (Japan)

^d NATIONAL FISHERIES UNIVERSITY   (Japan)

^e Research and Development Department Macrophi Inc   (Japan)

Author keywords

Allergic dermatitis; Hygiene hypothesis; Innate immunity; Lipopolysaccharide; Macrophage; Pantoea agglomerans; Review

Indexed keywords

ANTIALLERGIC AGENT; ANTIBIOTIC AGENT; IMMUNE POTENTIATOR FROM PANTOEA AGGLOMERANS 1; IMMUNOGLOBULIN E; IMMUNOSTIMULATING AGENT; LIPOPOLYSACCHARIDE; UNCLASSIFIED DRUG;

ANTIBIOTIC THERAPY; ATOPIC DERMATITIS; CLINICAL TRIAL; CONFERENCE PAPER; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG IDENTIFICATION; DRUG RESEARCH; DRUG STRUCTURE; HUMAN; IMMUNOGLOBULIN PRODUCTION; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOSTIMULATION; INNATE IMMUNITY; MACROPHAGE ACTIVATION; MOLECULAR WEIGHT; NONHUMAN; PANTOEA AGGLOMERANS; PRIORITY JOURNAL; SKIN ALLERGY; TH1 CELL; TH2 CELL;

ANIMALS; DERMATITIS, ALLERGIC CONTACT; HUMANS; IMMUNITY, INNATE; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; TH1 CELLS; TH2 CELLS;

EID: 75149161595     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (21)

1. Kohchi C, Inagawa H, Hino M, Oda M, Yoshida A, Hori H, Terada H, Makino K, Takiguchi K and Soma G: Utilization of macrophages in anticancer therapy: the macrophage network theory. Anticancer Res 24: 3311-3320, 2004.
2. Kettenmann H: Neuroscience: the brain's garbage men. Nature 446: 987-989, 2007
3. Koizumi S, Shigemoto-Mogami Y, Nasu-Tada K, Shinozaki Y, Ohsawa K, Tsuda M, Joshi BV, Jacobson KA, Kohsaka S and Inoue K: UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis. Nature 446: 1091-1095, 2007.
4. Nishizawa T, Inagawa H, Oshima H, Okutomi T, Tsukioka D, Iguchi M. Soam G and Mizuno D: Homeostasis as regulated by activated macrophage. I. Lipopolysaccharide (LPS) from wheat flour: isolation, purification and some biological activities. Chem Pharm Bull (Tokyo) 40: 479-483, 1992.
5. Giddens SR, Houliston GJ and Mahanty HK: The influence of antibiotic production and pre-emptive colonization on the population dynamics of Pantoea agglomerans (Erwinia herbicola) Eh1087 and Erwinia amylovora in planta. Environ Microbiol 5: 1016-1021, 2003.
6. Nunes C, Usall J, Teixido N, Fons E and Vinas I: Post-harvest biological control by Pantoea agglomerans (CPA-2) on Golden Delicious apples. J Appl Microbiol 92: 247-255, 2002.
7. Vanneste JL, Yu J and Beer SV: Role of antibiotic production by Erwinia herbicola Eh252 in biological control of Erwinia amylovora. J Bacteriol 174: 2785-2796, 1992.
8. Kariluoto S, Aittamaa M, Korhola M, Salovaara H, Vahteristo L and Piironen V: Effects of yeasts and bacteria on the levels of folates in rye sourdoughs. Int J Food Microbiol 106: 137-143, 2006.
9. Poltorak A, He X, Smirnova I, Liu MY, van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freulenberg M, Ricciardi-Castagnoli P, Layton B and Beutler B: Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085-2088, 1998.
10. Grabstein KH, Urdal DL, Tushinski RJ, Mochizuki DY, Price VL, Cantrell MA, Gills S and Conlon PJ: Induction of macrophage tumoricidal activity by granulocyte-macrophage colony-stimulating factor. Science 232: 506-508, 1986.
11. Itaya H, Imaizumi T, Yoshida H, Koyama M, Suzuki S and Satoh K: Expression of vascular endothelial growth factor in human monocyte/macrophages stimulated with lipopolysaccharide. Thromb Haemost 85: 171-176, 2001.
12. Kohchi C, Inagawa H, Nishizawa T, Yamaguchi T, Nagai S and Soma G: Applications of lipopolysaccharide derived from Pantoea agglomrans (IP-PAl) for health care based on macrophage network theory. J Biosci Bioeng 102: 485-496, 2006.
13. Inagawa H, Nishizawa T, Takagi K, Mizuno D and Soma G: Protective effect by intradermal administration of Pantoea agglomerans LPS (LPSp) and oral administration of ONO-4007, a lipid a derivative, on IgE-dependent ear swelling. Biotherapy 11: 464-466, 1997 (in Japanese).
14. Braun-Fahrlander C, Riedler J, Herz U, Eder W, Waser M, Grize L, Maisch S, Carr D, Gerlach F, Bufe A, Lauener RP, Schert R, Renz H, Nowak D, von Mutius E and Allergy and Endotoxin Study Team: Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med 347: 869-877, 2002.
15. Shirakawa T, Enomoto T, Shimazu S and Hopkin JM: The inverse association between tuberculin responses and atopic disorder. Science 275: 77-79, 1997.
16. von Mutius E, Braun-Fahrlander C, Schierl R, Riedler J, Ehlermann S, Maisch S, Waser M and Nowak D: Exposure to endotoxin or other bacterial components might protect against the development of atopy. Clin Exp Allergy 30: 1230-1234, 2000.
17. Lauener RP, Birchler T, Adamski J, Braun-Fahrländer C, Bufe A, Herz U, von Mutius E, Nowak D, Riedler J, Waser M, Sennhauser FH and ALEX study group: Expression of CD14 and toll-like receptor 2 in farmers' and non-farmers' children. Lancet 360: 465-466, 2002.
18. Reis e Sousa C, Stahl PD and Austyn JM: Phagocytosis of antigens by Langerhans cells in vitro. J Exp Med 178: 509-519, 1993.
19. MacPherson G, Milling S, Yrlid U, Cousins L, Turnbull E and Huang FP: Uptake of antigens from the intestine by dendritic cells. Ann N Y Acad Sci 1029: 75-82, 2004.
20. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S and Medzhitov R: Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 778: 229-241, 2004.
21. Kanzler H, Barrat FJ, Hessel EM and Coffman RL: Therapeutic targeting of innate immunity with toll-like receptor agonists and antagonists. Nat Med 15: 552-559, 2007.